News
3h
News-Medical.Net on MSNBody image concerns drive interest in GLP-1 weight loss drugs, study findsA new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...
Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results